South East Asia Cannabis Cultivation Market Size & Outlook, 2026-2034

South East Asia Cannabis Cultivation Market Insights

As per Deep Market Insights insights, the South East Asia Cannabis Cultivation Market stood at USD 590.28 Million in 2025 and is anticipated to grow to USD 1522.29 Million by 2034.
The South East Asia market is expected to advance at a CAGR of 11.01% from 2026 through 2034.
In 2025, Medical cannabis accounted for the highest share of the By Type market size.
During the forecast period, Medical cannabis is set to register the highest growth, making it the most lucrative By Type segment.

In 2025, South East Asia accounted for 2.29% of the global Cannabis Cultivation Market size.
By 2034, United States is expected to lead the global Cannabis Cultivation Market in terms of market size.
Within Asia Pacific, China is projected to dominate the regional Cannabis Cultivation Market size by 2034.
Japan is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 2012.08 Million by 2034.

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 590.28 Million
Market Size In 2034	USD 1522.29 Million
Largest segment	Medical cannabis
Units	Revenue in USD Million
CAGR	11.01% (2026-2034)
Segmnetation Covered
By Type	Medical cannabis Industrial hemp Recreational cannabis CBD-rich cannabis
By Cultivation Method	Indoor cultivation Outdoor cultivation Greenhouse cultivation Hydroponic cultivation
By Application	Pharmaceuticals Recreational use Food & beverages Cosmetics
By End User	Commercial growers Research institutions Pharmaceutical companies Consumers
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

By Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Medical cannabis	XX.x	XX.x	XX.x	236.11	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Industrial hemp	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Recreational cannabis	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
CBD-rich cannabis	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Cultivation Method	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Indoor cultivation	XX.x	XX.x	XX.x	256.24	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Outdoor cultivation	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Greenhouse cultivation	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Hydroponic cultivation	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Pharmaceuticals	XX.x	XX.x	XX.x	237.41	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Recreational use	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Food & beverages	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Cosmetics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By End User	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Commercial growers	XX.x	XX.x	XX.x	264.21	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research institutions	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pharmaceutical companies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Consumers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x